R. Russell

Oncology · with Baron · 2011

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom R. Russell trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Baron
  2. Nelson B. Watts

Who trusts R. Russell overall

  1. K. Redlich
  2. S. Khosla

Papers from R. Russell's perspective

Ordered by how strongly the researchers R. Russell trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis (Journal of Bone and Mineral Research)
  2. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (New England Journal of Medicine)
  3. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. (New England Journal of Medicine)
  4. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. (Journal of Pharmacology and Experimental Therapeutics)
  5. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. (New England Journal of Medicine)
  6. Zoledronic acid and clinical fractures and mortality after hip fracture. (New England Journal of Medicine)
  7. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. (Journal of oral and maxillofacial surgery)
  8. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section (British medical journal)
  9. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (New England Journal of Medicine)
  10. Denosumab in postmenopausal women with low bone mineral density. (New England Journal of Medicine)

Their papers